BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30733080)

  • 1. Long-term pre- and postconditioning with low doses of erythropoietin protects critically perfused musculocutaneous tissue from necrosis.
    Schmauss D; Weinzierl A; Weiss F; Egaña JT; Rezaeian F; Hopfner U; Schmauss V; Machens HG; Harder Y
    J Plast Reconstr Aesthet Surg; 2019 Apr; 72(4):590-599. PubMed ID: 30733080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin protects critically perfused flap tissue.
    Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
    Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner.
    Harder Y; Amon M; Schramm R; Contaldo C; Metzkow E; Matzen A; Rücker M; Vollmar B; Menger MD
    Surgery; 2009 Apr; 145(4):372-83. PubMed ID: 19303985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term preconditioning with erythropoietin reduces ischemia-induced skin necrosis.
    Rezaeian F; Wettstein R; Scheuer C; Schenck TL; Egaña JT; Machens HG; Menger MD; Harder Y
    Microcirculation; 2013 Nov; 20(8):693-702. PubMed ID: 23510335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced upregulation of endothelial nitric oxide synthase but not vascular endothelial growth factor prevents musculocutaneous tissue from ischemic damage.
    Rezaeian F; Wettstein R; Egger JF; Sandmann F; Rücker M; Tobalem M; Vollmar B; Menger MD; Harder Y
    Lab Invest; 2010 Jan; 90(1):40-51. PubMed ID: 19901910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local shockwave-induced capillary recruitment improves survival of musculocutaneous flaps.
    Tobalem M; Wettstein R; Pittet-Cuénod B; Vigato E; Machens HG; Lohmeyer JA; Rezaeian F; Harder Y
    J Surg Res; 2013 Oct; 184(2):1196-204. PubMed ID: 23582757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective blockade of endothelin-B receptor improves survival of critically perfused musculocutaneous flaps.
    Wettstein R; Mörsdorf P; Bächle A; Amon M; Pittet B; Menger MD; Harder Y
    Langenbecks Arch Surg; 2007 May; 392(3):331-8. PubMed ID: 17380348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice.
    Contaldo C; Meier C; Elsherbiny A; Harder Y; Trentz O; Menger MD; Wanner GA
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H274-83. PubMed ID: 17337594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin protects musculocutaneous tissue from ischemic necrosis by improving microvascular perfusion.
    Rezaeian F; Wettstein R; Scheuer C; Bäumker K; Bächle A; Vollmar B; Menger MD; Harder Y
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H603-10. PubMed ID: 22159999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative Intermittent Fasting Protects Ischemic Musculocutaneous Flap Tissue from Necrosis.
    Weinzierl A; Harder Y; Menger MD; Laschke MW
    Plast Reconstr Surg; 2023 May; 151(5):1030-1041. PubMed ID: 36729384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromelain Protects Critically Perfused Musculocutaneous Flap Tissue from Necrosis.
    Weinzierl A; Harder Y; Schmauss D; Menger MD; Laschke MW
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine attenuates leukocytic inflammation and microvascular perfusion failure in critically ischemic random pattern flaps.
    Bächle AC; Mörsdorf P; Rezaeian F; Ong MF; Harder Y; Menger MD
    Microvasc Res; 2011 Jul; 82(1):28-34. PubMed ID: 21513718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic and short-term erythropoietin treatment on random flap survival in rats: an experimental study.
    Saray A; Ozakpinar R; Koc C; Serel S; Sen Z; Can Z
    Laryngoscope; 2003 Jan; 113(1):85-9. PubMed ID: 12514388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia-induced up-regulation of heme oxygenase-1 protects from apoptotic cell death and tissue necrosis.
    Harder Y; Amon M; Schramm R; Rücker M; Scheuer C; Pittet B; Erni D; Menger MD
    J Surg Res; 2008 Dec; 150(2):293-303. PubMed ID: 18262556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of recombinant human basic fibroblast growth factor (bFGF) and erythropoietin (EPO) in prevention of skin flap ischemic necrosis in rats.
    Fayazzadeh E; Ahmadi SH; Rabbani S; Boroumand MA; Salavati A; Anvari MS
    Arch Iran Med; 2012 Sep; 15(9):553-6. PubMed ID: 22924373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caloric Restriction: A Novel Conditioning Strategy to Improve the Survival of Ischemically Challenged Musculocutaneous Random Pattern Flaps.
    Weinzierl A; Coerper M; Harder Y; Menger MD; Laschke MW
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Term Periodic Fasting Reduces Ischemia-Induced Necrosis in Musculocutaneous Flap Tissue.
    Weinzierl A; Coerper M; Harder Y; Menger MD; Laschke MW
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPO reverses defective wound repair in hypercholesterolaemic mice by increasing functional angiogenesis.
    Elsherbiny A; Högger DC; Borozadi MK; Schmidt CA; Plock J; Largo RD; Lindenblatt N; Giovanoli P; Contaldo C
    J Plast Reconstr Aesthet Surg; 2012 Nov; 65(11):1559-68. PubMed ID: 22704605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of systemic erythropoietin on ischemic wound healing in rats.
    Arslantaş MK; Arslantaş R; Tozan EN
    Ostomy Wound Manage; 2015 Mar; 61(3):28-33. PubMed ID: 25751848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock preconditioning reduces ischemic tissue necrosis by heat shock protein (HSP)-32-mediated improvement of the microcirculation rather than induction of ischemic tolerance.
    Harder Y; Amon M; Schramm R; Georgi M; Banic A; Erni D; Menger MD
    Ann Surg; 2005 Dec; 242(6):869-78, discussion 878-9. PubMed ID: 16327497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.